Article
Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects.
Nucleic acids research - 1 Sept 1997
Grassi G, Forlino A, Marini J C
Abstract excerpt
We report here the in vitro use of hammerhead ribozymes as an approach to the gene therapy of osteogenesis imperfecta (OI). Our strategy for the treatment of this dominant genetic disorder is based on selective reduction of the level of the mRNA transcripts from the mutant allele. We studied the in vitro cleavage activity of five different hammerhead ribozymes targeted against synthetic transcripts of two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
